crb® Real-Time RT-qPCR HIV-1

49,100$

 

Format: 100 rxns/Kit (Pack of 50 Kits)

Description

crb® Real-Time RT-qPCR HIV-1 kit is a real-time molecular diagnostic test for quantitative screening of human immunodeficiency virus (HIV) from viral RNA extracted from clinical specimens

Fast: 2.5 hours from sample to result.

Flexible: Includes internal control (IC) for monitoring of potential PCR inhibitions.

Convenient: Easy reaction setup and result analysis.

Highly Informative: 

      • Fulfills WHO guidelines for viral load monitoring.
      • Can detect and quantitate HIV-1 subtype M, N and O in a single tube.

The crb® Real-Time RT-qPCR HIV-1, is an in vitro diagnostic, total nucleic acid amplification test for the qualitative detection of Human Immunodeficiency Virus Type 1 (HIV-1) DNA and RNA (or total nucleic acid, TNA) in human plasma or dried blood spots for automated amplification and detection.

The test is a diagnostic test, indicated for individuals who are suspected to be actively infected with HIV-1. Detection of HIV-1 TNA is indicative of active HIV infection. Infants born to mothers infected with HIV-1 may have maternal antibodies to HIV-1, and the presence of HIV-1 nucleic acid in the infant indicates active HIV-1 infection. In adults, the test may be used as an aid in the diagnosis of HIV-1 infection.

SKU MD004
Detection HIV-1 subtype M, N and  O
Specimen Plasma
Kit Content
  • Reaction Mix
  • Primer-Probe Mix
  • Internal Control
  • PCR Grade Water
  • Positive Control
Compatible Instrument Quantitative PCR instrument
Test per kit 100

 

 

Registration Status

CE-IVD Registered
FDA-IVD Clinical Testing

IFU & SDS

Shelf life: 24 months

References

      1. Sison AV, Campos JM. Laboratory methods for earlz detection of human immunodeficiency virus type 1 in newborns and infants. Clin Microbiol Rev. 1992;5(3):238-247.
      2. Barennes H, Virak K, Rouet F, et al. Factors associated with the failure of first and second-line antiretroviral therapies therapy, a case control study in Cambodian HIV-1 infected children. BMC Res Notes. 2016;9:69.
      3. World Health Organization (WHO). Global update on HIV treatment 2013: Results, Impact and Opportunities. http://www.who.int/hiv/pub/progressreports/update2013/en/. Accessed March 2, 2017.
      4. Joint United Nations Programme on HIV/AIDS (UNAIDS). The GAP Report 2014: People Living with HIV. http://www.unaids.org/sites/default/files/media_asset/01_PeoplelivingwithHIV.pdf. Accessed March 2, 2017.
      5. United Nations Children’s Fund. Towards an AIDS-Free Generation—Children and AIDS: Sixth Stocktaking Report, 2013. http://www.unaids.org/sites/default/files/media_asset/20131129_stocktaking_report_children_aids_en_0.pdf. Accessed March 2, 2017.
      6. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global update on HIV treatment 2013: Results, Impact and Opportunities—WHO report in partnership with UNICEF and UNAIDS. http://www.unaids.org/en/resources/documents/2013/20130630_treatment_report. March 2, 2017.